Literature DB >> 28025239

Off-Label Use of Medical Devices in Children.

.   

Abstract

Despite widespread therapeutic needs, the majority of medical and surgical devices used in children do not have approval or clearance from the Food and Drug Administration (FDA) for use in pediatric populations. The clinical need for devices to diagnose and treat diseases or conditions occurring in children has led to the widespread and necessary practice in pediatric medicine and surgery of using approved devices for "off-label" or "physician-directed" applications that are not included in FDA-approved labeling. This practice is common and often appropriate, even with the highest-risk (class III) devices. The legal and regulatory framework used by the FDA for devices is complex, and economic or market barriers to medical and surgical device development for children are significant. Given the need for pediatric medical and surgical devices and the challenges to pediatric device development, off-label use is a necessary and appropriate part of care. In addition, because of the relatively uncommon nature of pediatric conditions, FDA clearance or approval often requires other regulatory pathways (eg, Humanitarian Device Exemption), which can cause confusion among pediatricians and payers about whether a specific use, even of an approved device, is considered experimental. This policy statement describes the appropriateness of off-label use of devices in children; the use of devices approved or cleared through the FDA regulatory processes, including through the Humanitarian Device Exemption; and the important need to increase pediatric device labeling information for all devices and especially those that pose the highest risk to children.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2017        PMID: 28025239     DOI: 10.1542/peds.2016-3439

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021.

Authors:  Susmitha Wunnava; Timothy A Miller; Claire Narang; Meena Nathan; Florence T Bourgeois
Journal:  JAMA       Date:  2022-08-09       Impact factor: 157.335

Review 2.  Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease.

Authors:  Abhay A Divekar; Yousef M Arar; Stephen Clark; Animesh Tandon; Thomas M Zellers; Surendranath R Veeram Reddy
Journal:  Children (Basel)       Date:  2022-04-02

3.  Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices).

Authors:  A G Fraser; R G H H Nelissen; P Kjærsgaard-Andersen; P Szymański; T Melvin; P Piscoi
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-05-05

Review 4.  Clinical pharmacology considerations for children supported with ventricular assist devices.

Authors:  Jennifer Sherwin; Elizabeth Thompson; Kevin D Hill; Kevin Watt; Andrew J Lodge; Daniel Gonzalez; Christoph P Hornik
Journal:  Cardiol Young       Date:  2018-07-11       Impact factor: 1.093

5.  Advancing pediatric medical device development via non-dilutive NIH SBIR/STTR grant funding.

Authors:  Raphael C Sun; Ishan Kamat; Achu G Byju; Matthew Wettergreen; Michael J Heffernan; Richard Willson; Balakrishna Haridas; Chester J Koh
Journal:  J Pediatr Surg       Date:  2021-01-25       Impact factor: 2.549

6.  A model for overcoming challenges in academic pediatric medical device innovation.

Authors:  Gwenyth A Fischer; Sandra M Wells; Jodi F Rebuffoni; Brittni M Peterson; Tucker W LeBien
Journal:  J Clin Transl Sci       Date:  2019-02

7.  Comparison of supportive regulatory measures for pediatric medical device development in Japan and the United States.

Authors:  Sara Takahashi; Kiyotaka Iwasaki; Haruki Shirato; Mami Ho; Mitsuo Umezu
Journal:  J Artif Organs       Date:  2020-10-20       Impact factor: 1.731

8.  Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications.

Authors:  Samuel J Lee; Lauren Cho; Eyal Klang; James Wall; Stefano Rensi; Benjamin S Glicksberg
Journal:  JAMA Netw Open       Date:  2021-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.